MedTrace Logo

DOLORisk: Research on Risk Factors and Determinants for Neuropathic Pain

NCT04888455 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1550

Last updated 2022-11-08

No results posted yet for this study

Summary

Patients with neuropathic pain of multiple etiologies and a control cohort of patients with the same neuropathic entities who did not develop neuropathic pain are examined clinically, phenotyped with QST and questionnaires. Both groups are analyzed in order to find risk factors for painful neuropathy.

Conditions

  • Neuropathic Pain

Interventions

DIAGNOSTIC_TEST

Quantitative sensory testing (QST)

Demographic data, pain characteristics, health status, emotional well-being, personality and lifestyle are assessed by questionnaires. Additionally, all patients underwent a clinical neurological examination and quantitative sensory testing (QST) according to the German Research Network on Neuropathic Pain (DFNS).

Sponsors & Collaborators

  • Horizon 2020 - European Commission

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • University of Oxford

    collaborator OTHER

  • Imperial College London

    collaborator OTHER

  • Technion, Israel Institute of Technology

    collaborator OTHER

  • University of Aarhus

    collaborator OTHER

  • Aarhus University Hospital

    collaborator OTHER

  • University of Kiel

    lead OTHER

Principal Investigators

  • David Bennett, Prof. · University of Oxford

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04888455 on ClinicalTrials.gov